Investment Thesis
Solventum generates substantial revenue ($2.0B) with adequate gross margins (54.7%), but faces critical operational challenges with negative operating cash flow (-$189M) and profitability struggles (0.6% net margin, 0.3% ROE). The company is burning cash operationally while carrying $4.6B debt, creating financial stress that requires substantial operational improvement before fundamental recovery.
Strengths
- Gross margin of 54.7% indicates reasonable pricing power and product quality in medical devices sector
- Maintains $561M cash balance and $2.0B revenue base providing operational runway
- Medical device sector has structurally stable demand fundamentals
Risks
- Negative operating cash flow of -$189M indicates core business model is not generating cash despite revenue
- Extremely low profitability with 0.6% net margin and abysmal 0.3% ROE/0.1% ROA suggesting operational inefficiency
- Deteriorating liquidity position with current ratio of 1.07x and quick ratio of 0.75x combined with $4.6B debt burden
Key Metrics to Watch
- Operating cash flow inflection point - must turn positive to validate business health
- Operating margin expansion trajectory - need 8-10%+ target to sustain leverage
- Revenue growth acceleration - 0.9% YoY is insufficient for debt service sustainability
Financial Metrics
Revenue
2.0B
Net Income
13.0M
EPS (Diluted)
$0.07
Free Cash Flow
-273.0M
Total Assets
14.1B
Cash
561.0M
Profitability Ratios
Gross Margin
54.7%
Operating Margin
4.0%
Net Margin
0.6%
ROE
0.3%
ROA
0.1%
FCF Margin
-13.6%
Balance Sheet & Liquidity
Current Ratio
1.07x
Quick Ratio
0.75x
Debt/Equity
0.92x
Debt/Assets
64.8%
Interest Coverage
N/A
Long-term Debt
4.6B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-07T10:37:11.216142 |
Data as of: 2026-03-31 |
Powered by Claude AI